X-11762184-A-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_078629.4(MSL3):c.520A>G(p.Ile174Val) variant causes a missense change. The variant allele was found at a frequency of 0.000116 in 1,162,473 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 49 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.00013 ( 0 hom. 49 hem. )
Consequence
MSL3
NM_078629.4 missense
NM_078629.4 missense
Scores
2
13
Clinical Significance
Conservation
PhyloP100: 6.02
Genes affected
MSL3 (HGNC:7370): (MSL complex subunit 3) This gene encodes a nuclear protein that is similar to the product of the Drosophila male-specific lethal-3 gene. The Drosophila protein plays a critical role in a dosage-compensation pathway, which equalizes X-linked gene expression in males and females. Thus, the human protein is thought to play a similar function in chromatin remodeling and transcriptional regulation, and it has been found as part of a complex that is responsible for histone H4 lysine-16 acetylation. This gene can undergo X inactivation. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 7 and 8. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.05978009).
BP6
?
Variant X-11762184-A-G is Benign according to our data. Variant chrX-11762184-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2409871.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-11762184-A-G is described in Lovd as [Likely_benign].
BS2
?
High Hemizygotes in GnomAdExome at 8 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MSL3 | NM_078629.4 | c.520A>G | p.Ile174Val | missense_variant | 6/13 | ENST00000312196.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MSL3 | ENST00000312196.10 | c.520A>G | p.Ile174Val | missense_variant | 6/13 | 1 | NM_078629.4 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.0000178 AC: 2AN: 112580Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34722
GnomAD3 genomes
?
AF:
AC:
2
AN:
112580
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34722
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000144 AC: 22AN: 153153Hom.: 0 AF XY: 0.000163 AC XY: 8AN XY: 49219
GnomAD3 exomes
AF:
AC:
22
AN:
153153
Hom.:
AF XY:
AC XY:
8
AN XY:
49219
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000127 AC: 133AN: 1049893Hom.: 0 Cov.: 23 AF XY: 0.000149 AC XY: 49AN XY: 329811
GnomAD4 exome
AF:
AC:
133
AN:
1049893
Hom.:
Cov.:
23
AF XY:
AC XY:
49
AN XY:
329811
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000178 AC: 2AN: 112580Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34722
GnomAD4 genome
?
AF:
AC:
2
AN:
112580
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34722
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
?
AF:
AC:
29
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 17, 2022 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | MSL3: BP4, BS2 - |
MSL3-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 17, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T;T;T;.;.;.;.;.;.;T;T;.;T;T;T;T;.;.;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D;D;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;.;.;N;N;.;.;.;.;.;N;N;.;.;.;.;.;.;.;.;.
REVEL
Benign
Sift
Benign
T;D;D;.;.;D;.;.;.;.;.;.;T;T;.;.;.;.;.;.;.;.;.
Sift4G
Benign
T;T;T;.;.;T;.;.;.;.;.;.;T;T;.;.;.;.;.;.;.;.;.
Polyphen
0.098
.;B;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
MVP
MPC
0.56
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at